Export controls turn Nvidia's board into a target in D&O suits
A shareholder derivative suit filed November 11, 2026 accuses Nvidia's board of ignoring export-control red flags. A Delaware case targets Applied Materials after its $252.5 million BIS penalty over SMIC.
By Nathan Brooks
5 min read

What's News
- Nvidia shareholder derivative suit filed November 11, 2026 in the Northern District of California against Jensen Huang and individual board members.
- Applied Materials agreed on February 11, 2026 to pay $252.5 million to the Commerce Department's Bureau of Industry and Security over alleged ion-implanter exports to SMIC.
- Applied Materials' Delaware Court of Chancery derivative complaint was filed October 26, 2026 and targets the board's oversight.
- The Applied Materials complaint alleges SMIC sales generated more than $100 million in annual revenue and involved a secret "dual-build plan" shifting production from Massachusetts to South Korea.
- Super Micro Computer faced export-control securities suits in March 2026 and October 2024; Alibaba was sued in August 2026 and Webull last month.
By Nathan Brooks
Applied Materials agreed on February 11, 2026 to pay $252.5 million to the U.S. Department of Commerce's Bureau of Industry and Security. That penalty, over alleged exports of controlled ion-implanter technology to SMIC, now anchors a Delaware derivative lawsuit against the company's own board.
The parallel case is sharper for most investors. A shareholder filed a derivative suit in the Northern District of California on November 11, 2026, naming former CEO Jensen Huang and the individual members of Nvidia's board of directors. It follows a securities class action over Huang's conduct and reframes the whole story as an export-control problem.
What does the Nvidia complaint actually allege?
The complaint opens by alleging that the U.S. government treats Nvidia's high-end graphics processing units "as national-security assets and forbids their export to China." It adds that "compliance with those export controls, and protection of the Company's technology from foreign intelligence services, are mission-critical to Nvidia."
The stakes are spelled out. A lapse in controls, the complaint says, "threatens its government relationships, its license to sell abroad, its reputation and consequently the value of the company." On that theory, export controls sit on the critical path of the business, and a board that misses them endangers the company it governs.
The complaint also alleges the board allowed Huang to "keep a romantic relationship with a senior executive of an NVIDIA customer" despite warning signs that were "public and specific." It says Huang "breached his duty of loyalty by concealing a conflict that put the Company at risk and by making and allowing misleading public statements."
The remaining directors, the complaint alleges, "breached their duty of oversight by consciously ignoring red flags about the CEO, a customer under export-control investigation, and a foreign intelligence threat that was intent on infiltrating NVIDIA to allow espionage for China." The plaintiff seeks recovery of Nvidia's losses plus governance reforms. A story that began as a CEO's private conduct now reads as a duty-of-oversight case with a much larger balance sheet behind it.
How the Applied Materials case is built
The Applied Materials complaint, a redacted copy of which is public, was filed in the Delaware Court of Chancery on October 26, 2026. It grows directly out of the February 11, 2026 penalty agreement, and its target is the board rather than management.
BIS contended that Applied Materials' sales to SMIC violated an express U.S. ban on exporting ion implanters classified as "ECCN 3B991" technology, because of the "unacceptable risk" that "SMIC would divert that technology to the Chinese military." BIS alleged a secret "dual-build plan" that shifted part of the ion-implanter manufacturing process from Massachusetts to South Korea. That plan was implemented "solely to supply one product (ion implanters) to one customer (SMIC), while AMAT continued to ship ion implanters to every other customer directly" from its Massachusetts plant. The complaint says those SMIC sales delivered more than $100 million in annual revenue — against which the $252.5 million penalty is roughly two and a half times larger.
Then comes the board allegation. Documents obtained through a books and records request, the complaint says, "support the plausible inference" that AMAT's board "either knew of the 'dual-build plan' to continue supplying SMIC with ion implanters or consciously disregarded the likelihood that those sales continued." The facts, it argues, support the inference that the Board "(1) knowingly supported a business plan that prioritized profits over U.S. national security, or (2) consciously ignored red flags that senior executives were racing through two giant regulatory stop signs." The complaint alleges the board "breached their fiduciary duties of loyalty under Delaware law for exercising their oversight responsibilities in bad faith."
What does this change for boards with China exposure?
Ask what changes for a company with any China footprint, and the answer is that export-control compliance now carries personal fiduciary exposure rather than sitting in a compliance manual. Internal documents become the raw material of the case, as the books-and-records request in the Applied Materials complaint shows. A dual manufacturing footprint, arranged to keep a product legally distant from a restricted customer, can read to a court as a deliberate workaround rather than a logistics decision.
The pattern runs well beyond chipmakers. In March 2026, a plaintiff shareholder sued Super Micro Computer and certain of its executives, alleging the company concealed efforts to export high-end Nvidia chips to China in violation of U.S. export controls. That was not Super Micro's first such suit; in October 2024, another plaintiff shareholder alleged the company misrepresented its compliance with trade control regulations restricting exports to Russia.
China-adjacent claims also run outside export controls. Last month, digital brokerage platform Webull was hit with a securities suit alleging it misrepresented the extent of its operational ties to China and understated the regulatory and geopolitical risks of those ties. In August 2026, U.S.-listed Chinese internet company Alibaba was hit with a securities class action alleging it misrepresented the risks associated with its alleged status as a "Chinese military company" under U.S. law. Sarah Abrams, who wrote the underlying legal analysis, notes that these developments raise a wider question: whether China itself has become a D&O liability risk factor, not just for U.S.-listed companies based in China, but for any company with a China connection.
The same claim template now covers trade sanctions, tariffs, operational difficulties arising from the Iran-U.S. War, anti-money laundering, supply chain vulnerabilities, cross-border money transfers, and the threat of further nation-state conflict. For companies with significant cross-border operations, Abrams writes, those complications "can and frequently do result in D&O claims."
Where this goes into 2027
The direction is not ambiguous. Abrams expects geopolitical concerns to remain a significant source of D&O risk in the months ahead, and China supplies the recurring thread in the cases filed so far. As 2027 approaches, her conclusion is that geopolitical issues have become an important and arguably growing source of D&O risk — which means export controls now belong on a director's risk register, not only in a trade-compliance file.
Source: insurancejournal.com
More from Nathan Brooks
Show full bio
News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.
2,426 articles